이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Early Neuropsychological Rehabilitation and Family Psychoeducation After Ischemic Stroke

2026년 9월 1일 업데이트: Jordi Sanchez Monteagudo, Althaia Xarxa Assistencial Universitària de Manresa

Efficacy of Early Neuropsychological Rehabilitation and Family Psychoeducation After Ischemic Stroke: A Randomized 2×2 Factorial Clinical Trial With Blinded Outcome Assessment

Cognitive impairment and reduced quality of life are frequent consequences of ischemic stroke and can also affect family caregivers, who often assume caregiving responsibilities with limited preparation. Evidence regarding rehabilitation interventions initiated during the early poststroke period remains limited.

This randomized clinical trial evaluates two independent interventions initiated after baseline assessment and randomization, approximately 20 days after the index stroke: a structured computerized neuropsychological rehabilitation program for the patient and a structured psychoeducational program for the primary family caregiver. A 2×2 factorial design allows the main effect of each intervention to be estimated within a single sample and permits an exploratory assessment of their interaction.

The primary outcome is quality of life at 3 months after stroke, measured using the CAVIDACE total direct score and completed by a family informant. Secondary outcomes include cognitive performance, functional status, mood, and caregiver burden. Molecular biomarkers and acute structural neuroimaging variables are examined as exploratory outcomes.

연구 개요

상태

모집하지 않고 적극적으로

정황

개입 / 치료

상세 설명

Background and rationale

Cognitive deficits are frequent after ischemic stroke and may adversely affect functional recovery, quality of life, emotional well-being, and participation in rehabilitation. Although recovery trajectories vary considerably between individuals, the early poststroke period represents an important phase of cognitive, functional, and psychosocial adaptation. Evidence regarding structured cognitive rehabilitation initiated during this early period remains limited.

Stroke also has important consequences for family members and informal caregivers. Caregivers may experience substantial burden associated with functional dependence, cognitive and behavioral changes, emotional difficulties, and the demands of providing ongoing support. Structured psychoeducational interventions may help caregivers understand the consequences of stroke and develop appropriate strategies for supporting recovery and adaptation.

This trial evaluates both dimensions simultaneously by examining computerized neuropsychological rehabilitation directed at the patient and structured family psychoeducation directed at the primary family caregiver.

Procedures

Participants are recruited during the acute phase of ischemic stroke, within 96 hours of symptom onset. Baseline assessment of the primary outcome is performed approximately 20 days after the index stroke, before randomization and before either intervention begins. Randomization is performed after completion of this baseline assessment.

Allocation is stratified according to receipt of acute reperfusion therapy, defined as intravenous thrombolysis and/or mechanical thrombectomy versus no reperfusion treatment. Reperfusion status is used as a prespecified prognostic stratification factor. Randomization is implemented through the REDCap electronic data capture system using randomly permuted blocks of variable size. The allocation sequence is inaccessible to personnel responsible for recruitment and eligibility assessment, and the next treatment assignment cannot be anticipated.

Both intervention factors begin after randomization, approximately 20 days after the index stroke, and continue for approximately 12 weeks. The primary outcome assessment is scheduled at 3 months after stroke, corresponding to 90 days ±14 days. An optional 12-month follow-up constitutes an observational extension and is not part of the primary randomized trial analysis.

Participants allocated to computerized neuropsychological rehabilitation receive 24 sessions of structured computerized cognitive training using the Guttmann NeuroPersonalTrainer platform. Sessions last 45 minutes and are delivered twice weekly over approximately 12 weeks. The sequence and duration of the cognitive exercises are standardized, while task difficulty is individually adjusted by the platform according to previous performance. The intervention targets attention, processing speed, memory, executive functions, language, visuospatial abilities, and functional transfer of trained strategies.

Participants not allocated to computerized neuropsychological rehabilitation receive an active digital control condition consisting of simple recreational digital activities matched in duration and frequency. These activities do not incorporate adaptive difficulty, structured therapeutic progression, or cognitive performance feedback.

Primary family caregivers allocated to structured family psychoeducation receive six individual 45-minute sessions delivered by videoconference approximately every 2 weeks over 12 weeks. The program includes stroke education, the role of the family in recovery, emotional management, behavioral difficulties, cognitive restructuring, relaxation, self-compassion, mindfulness-based coping strategies, and behavioral activation. Caregivers are not trained in cognitive rehabilitation techniques in order to preserve the conceptual independence of the two factorial intervention components.

Primary family caregivers not allocated to structured psychoeducation receive a brief informational leaflet at the approximately 20-day visit after randomization. The leaflet provides general information about stroke and its physical, communicative, cognitive, emotional, and behavioral consequences, together with recommended educational resources. It does not include behavioral management strategies, structured psychoeducational techniques, or cognitive rehabilitation training.

All participants continue to receive usual poststroke clinical care. Physiotherapy, occupational therapy, speech therapy, convalescence care, and other rehabilitation services may be prescribed according to clinical indication and are recorded as co-interventions.

Outcomes and analysis

The primary outcome is the CAVIDACE total direct score at 3 months after stroke, completed by a family informant. The total direct score ranges from 0 to 192, with higher scores indicating better quality of life. The corresponding CAVIDACE score obtained approximately 20 days after stroke is used as the baseline covariate in the primary analysis.

Secondary outcomes are organized into two independent prespecified families. The family associated with computerized neuropsychological rehabilitation includes the global neuropsychological composite score, Modified Rankin Scale, Barthel Index, and Lawton-Brody Instrumental Activities of Daily Living Scale. The family associated with structured family psychoeducation includes the Zarit Burden Interview, Hospital Anxiety and Depression Scale Anxiety subscale, Hospital Anxiety and Depression Scale Depression subscale, and Beck Depression Inventory-II.

The primary analysis follows the intention-to-treat principle and uses an analysis of covariance model including the main effects of both intervention factors, baseline CAVIDACE, and the randomization stratum. The F1×F2 interaction is examined in a separate exploratory model.

Exploratory biological outcomes include brain-derived neurotrophic factor, glial fibrillary acidic protein, interleukin-6, C-reactive protein, and S100 calcium-binding protein B. Acute structural magnetic resonance imaging variables include lesion volume, lesion location, vascular territory, Oxfordshire Community Stroke Project classification, and apparent diffusion coefficient. These analyses are considered exploratory and hypothesis-generating.

A prespecified Statistical Analysis Plan defining the estimands, analysis models, handling of missing data, multiplicity, and sensitivity analyses was finalized and signed before database lock and before any comparative analysis of study outcomes.

연구 유형

중재적

등록 (실제)

81

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Barcelona
      • Manresa, Barcelona, 스페인, 08243
        • Hospital Universitari Sant Joan de Déu de Manresa, Fundació Althaia

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 성인
  • 고령자

건강한 자원 봉사자를 받아들입니다

아니

설명

Inclusion Criteria:

  • First-ever ischemic stroke, excluding transient ischemic attack
  • Age 18 years or older
  • Inclusion within 96 hours of symptom onset
  • Functional independence before the index stroke, defined as a prestroke Modified Rankin Scale score ≤1
  • Diagnosis of ischemic stroke classified according to the Oxfordshire Community Stroke Project as total anterior circulation infarction, partial anterior circulation infarction, posterior circulation infarction, or lacunar infarction
  • Capacity to provide written informed consent at enrollment or, in cases of temporary incapacity, availability of a legally authorized representative to provide consent on the participant's behalf, followed by participant re-consent if decision-making capacity is regained

Exclusion Criteria:

  • Previous neurological or psychiatric disease associated with cognitive impairment
  • Severe systemic disease
  • Life expectancy of less than 1 year
  • Severe stroke, defined as a National Institutes of Health Stroke Scale score >19 at admission
  • Alcohol or other substance abuse, excluding tobacco use
  • Clinically relevant aphasia preventing comprehension of neuropsychological test instructions, operationalized as a score <5 on the fluency subscale of the Western Aphasia Battery
  • Sensory impairment preventing valid neuropsychological assessment or use of the intervention materials, such as severe visual or hearing impairment
  • Functional illiteracy, defined as inability to read and understand simple written instructions

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 요인 할당
  • 마스킹: 하나의

무기와 개입

참가자 그룹 / 팔
개입 / 치료
활성 비교기: Group 1: Control
Simple recreational digital activities matched to the computerized neuropsychological rehabilitation condition in session duration and frequency. The activities do not incorporate adaptive difficulty, structured therapeutic progression, or cognitive performance feedback.
A brief informational leaflet provided at the approximately 20-day visit after randomization. The leaflet includes general information about stroke and its physical, communicative, cognitive, emotional, and behavioral consequences, together with recommended educational resources. It does not include behavioral management strategies, structured psychoeducational techniques, or cognitive rehabilitation training.
실험적: Group 2: Neuropsychological rehabilitation
A brief informational leaflet provided at the approximately 20-day visit after randomization. The leaflet includes general information about stroke and its physical, communicative, cognitive, emotional, and behavioral consequences, together with recommended educational resources. It does not include behavioral management strategies, structured psychoeducational techniques, or cognitive rehabilitation training.
Structured computerized cognitive training using the Guttmann NeuroPersonalTrainer platform. The intervention comprises 24 sessions of 45 minutes, delivered twice weekly over approximately 12 weeks, starting after randomization approximately 20 days after the index stroke. The sequence and duration of cognitive exercises are standardized, while task difficulty is individually adjusted by the platform according to previous performance.
실험적: Group 3: Family psychoeducation
Simple recreational digital activities matched to the computerized neuropsychological rehabilitation condition in session duration and frequency. The activities do not incorporate adaptive difficulty, structured therapeutic progression, or cognitive performance feedback.
Six individual 45-minute sessions delivered by videoconference to the primary family caregiver approximately every 2 weeks over 12 weeks. The program covers stroke education, the role of the family in recovery, emotional management, behavioral difficulties, cognitive restructuring, relaxation, self-compassion, mindfulness-based coping strategies, and behavioral activation. Caregivers are not trained in cognitive rehabilitation techniques.
실험적: Group 4: Combined intervention
Structured computerized cognitive training using the Guttmann NeuroPersonalTrainer platform. The intervention comprises 24 sessions of 45 minutes, delivered twice weekly over approximately 12 weeks, starting after randomization approximately 20 days after the index stroke. The sequence and duration of cognitive exercises are standardized, while task difficulty is individually adjusted by the platform according to previous performance.
Six individual 45-minute sessions delivered by videoconference to the primary family caregiver approximately every 2 weeks over 12 weeks. The program covers stroke education, the role of the family in recovery, emotional management, behavioral difficulties, cognitive restructuring, relaxation, self-compassion, mindfulness-based coping strategies, and behavioral activation. Caregivers are not trained in cognitive rehabilitation techniques.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Quality of life (CAVIDACE total direct score)
기간: 3 months post-stroke (day 90 ± 14 days)
The CAVIDACE scale (Quality of Life in Acquired Brain Injury) is completed by a family informant. The total direct score ranges from 0 to 192, with higher scores indicating better quality of life. The corresponding CAVIDACE score obtained approximately 20 days after stroke is used as the baseline covariate in the primary analysis.
3 months post-stroke (day 90 ± 14 days)

2차 결과 측정

결과 측정
측정값 설명
기간
Global neuropsychological composite score
기간: 3 months post-stroke (90 days ±14 days)
The global neuropsychological composite score is calculated as the unweighted mean of standardized z scores across five cognitive domains: attention and processing speed, memory and learning, language, executive functioning, and visuospatial functioning. Individual neuropsychological test scores are standardized using the corresponding normative data. At least three valid cognitive-domain scores are required to calculate the composite. Because the composite consists of standardized z scores, it has no fixed theoretical minimum or maximum. Higher scores indicate better global cognitive performance.
3 months post-stroke (90 days ±14 days)
Modified Rankin Scale
기간: 3 months post-stroke (90 days ±14 days)
The Modified Rankin Scale assesses global disability after stroke on an ordinal scale ranging from 0 to 6. A score of 0 indicates no symptoms, whereas a score of 6 indicates death. Higher scores indicate greater disability and a worse outcome.
3 months post-stroke (90 days ±14 days)
Barthel Index
기간: 3 months post-stroke (90 days ±14 days)
The Barthel Index assesses independence in basic activities of daily living. The total score ranges from 0 to 100. Higher scores indicate greater functional independence and a better outcome.
3 months post-stroke (90 days ±14 days)
Lawton-Brody Instrumental Activities of Daily Living Scale
기간: 3 months post-stroke (90 days ±14 days)
The Lawton-Brody Instrumental Activities of Daily Living Scale assesses independence in instrumental activities of daily living. The 8-item version used in this study ranges from 0 to 8. Higher scores indicate greater independence and a better functional outcome.
3 months post-stroke (90 days ±14 days)
Zarit Burden Interview, 22-item version
기간: 3 months post-stroke (90 days ±14 days)
The 22-item Zarit Burden Interview assesses perceived caregiver burden. Each item is rated from 0 to 4, yielding a total score ranging from 0 to 88. Higher scores indicate greater perceived caregiver burden and a worse outcome.
3 months post-stroke (90 days ±14 days)
Hospital Anxiety and Depression Scale - Anxiety Subscale (HADS-A)
기간: 3 months post-stroke (90 days ±14 days)
The Hospital Anxiety and Depression Scale Anxiety subscale consists of 7 items and yields a total score ranging from 0 to 21. Higher scores indicate greater severity of anxiety symptoms and a worse outcome.
3 months post-stroke (90 days ±14 days)
Hospital Anxiety and Depression Scale - Depression Subscale (HADS-D)
기간: 3 months post-stroke (90 days ±14 days)
The Hospital Anxiety and Depression Scale Depression subscale consists of 7 items and yields a total score ranging from 0 to 21. Higher scores indicate greater severity of depressive symptoms and a worse outcome.
3 months post-stroke (90 days ±14 days)
Beck Depression Inventory-II
기간: 3 months post-stroke (90 days ±14 days)
The Beck Depression Inventory-II consists of 21 items and yields a total score ranging from 0 to 63. Higher scores indicate greater severity of depressive symptoms and a worse outcome.
3 months post-stroke (90 days ±14 days)

기타 결과 측정

결과 측정
측정값 설명
기간
Biomarker concentrations (BDNF, GFAP, IL-6, CRP, and S100B)
기간: Acute hospitalization (≤96 hours after stroke), approximately 20 days after stroke, and 3 months after stroke (90 days ±14 days); optional observational assessment at 12 months
Exploratory longitudinal biomarker outcomes including brain-derived neurotrophic factor, glial fibrillary acidic protein, interleukin-6, C-reactive protein, and S100 calcium-binding protein B. Biomarker concentrations are examined in relation to clinical and cognitive recovery.
Acute hospitalization (≤96 hours after stroke), approximately 20 days after stroke, and 3 months after stroke (90 days ±14 days); optional observational assessment at 12 months
Acute structural MRI lesion characteristics
기간: Acute hospitalization (≤96 hours after stroke)
Exploratory variables derived from acute structural magnetic resonance imaging include lesion volume, lesion location, vascular territory, Oxfordshire Community Stroke Project classification, and apparent diffusion coefficient.
Acute hospitalization (≤96 hours after stroke)
Montreal Cognitive Assessment (MoCA)
기간: Acute hospitalization (≤96 hours), approximately 20 days after stroke, 3 months after stroke, and optional observational follow-up at 12 months.
The Montreal Cognitive Assessment evaluates global cognitive performance. Total scores range from 0 to 30, with higher scores indicating better global cognitive performance.
Acute hospitalization (≤96 hours), approximately 20 days after stroke, 3 months after stroke, and optional observational follow-up at 12 months.
Functional Ambulation Category (FAC)
기간: Acute hospitalization (≤96 hours), approximately 20 days after stroke, 3 months after stroke, and optional observational follow-up at 12 months.
The Functional Ambulation Category assesses functional walking ability. Scores range from 0 to 5, with higher scores indicating greater independence in ambulation.
Acute hospitalization (≤96 hours), approximately 20 days after stroke, 3 months after stroke, and optional observational follow-up at 12 months.
Hessisch Oldendorf Risk of Falling Scale (HOSS)
기간: Acute hospitalization (≤96 hours), approximately 20 days after stroke, 3 months after stroke, and optional observational follow-up at 12 months.
The Hessisch Oldendorf Risk of Falling Scale assesses risk of falling. Total scores range from 0 to 22, with higher scores indicating greater risk of falling.
Acute hospitalization (≤96 hours), approximately 20 days after stroke, 3 months after stroke, and optional observational follow-up at 12 months.
Depression Signs Scale (ESD)
기간: Acute hospitalization (≤96 hours), approximately 20 days after stroke, 3 months after stroke, and optional observational follow-up at 12 months.
The Depression Signs Scale (Escala de Signes de Depressió), developed by the Catalan Agency for Health Quality and Assessment, comprises 6 dichotomously scored items and yields a total score ranging from 0 to 6. Higher scores indicate a greater number of observed signs suggestive of mood disturbance.
Acute hospitalization (≤96 hours), approximately 20 days after stroke, 3 months after stroke, and optional observational follow-up at 12 months.

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

협력자

수사관

  • 수석 연구원: Jordi Sanchez Monteagudo, Hospital Universitari Sant Joan de Déu de Manresa, Fundació Althaia

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2025년 11월 19일

기본 완료 (추정된)

2026년 11월 25일

연구 완료 (추정된)

2027년 7월 27일

연구 등록 날짜

최초 제출

2026년 8월 26일

QC 기준을 충족하는 최초 제출

2026년 8월 26일

처음 게시됨 (실제)

2026년 8월 28일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 3일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 1일

마지막으로 확인됨

2026년 8월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • CER-21-39

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 계획 설명

Following publication of the primary trial results, deidentified individual participant data underlying the published analyses, together with the corresponding data dictionary where applicable, may be made available upon reasonable request. Access will be subject to approval by Fundació Althaia and compliance with applicable ethical, institutional, informed-consent, and data-protection requirements.

IPD 공유 기간

Beginning after publication of the primary trial results.

IPD 공유 액세스 기준

Access may be granted following a reasonable scientific request, review and approval by Fundació Althaia, and compliance with applicable ethical, institutional, informed-consent, and data-protection requirements.

IPD 공유 지원 정보 유형

  • 연구_프로토콜
  • 수액

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .